|
HAUS1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.27429999999362E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.62959999999402E-05 |
| Normal-vs-Stage2 |
7.150100E-04 |
| Normal-vs-Stage3 |
1.543500E-03 |
| Normal-vs-Stage4 |
1.191640E-04 |
| Stage1-vs-Stage2 |
5.419400E-01 |
| Stage1-vs-Stage3 |
6.525600E-01 |
| Stage1-vs-Stage4 |
3.269800E-01 |
| Stage2-vs-Stage3 |
3.978600E-01 |
| Stage2-vs-Stage4 |
8.476800E-01 |
| Stage3-vs-Stage4 |
2.369600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.89094999999417E-05 |
| Normal-vs-AfricanAmerican |
2.222500E-02 |
| Normal-vs-Asian |
1.041640E-01 |
| Caucasian-vs-AfricanAmerican |
4.354600E-01 |
| Caucasian-vs-Asian |
9.462400E-01 |
| AfricanAmerican-vs-Asian |
7.534400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.72819999999518E-06 |
| Normal-vs-Female |
3.364600E-03 |
| Male-vs-Female |
3.757900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.419000E-04 |
| Normal-vs-Age(41-60Yrs) |
1.640760E-04 |
| Normal-vs-Age(61-80Yrs) |
1.016890E-04 |
| Normal-vs-Age(81-100Yrs) |
6.242600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.142770E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.189850E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.228200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.459200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.724400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.925200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.210100E-02 |
| Normal-vs-Grade 2 |
2.92629999998351E-06 |
| Normal-vs-Grade 3 |
3.238100E-04 |
| Normal-vs-Grade 4 |
1.538100E-02 |
| Grade 1-vs-Grade 2 |
3.608200E-01 |
| Grade 1-vs-Grade 3 |
7.483600E-01 |
| Grade 1-vs-Grade 4 |
8.105200E-01 |
| Grade 2-vs-Grade 3 |
3.045400E-01 |
| Grade 2-vs-Grade 4 |
1.302570E-01 |
| Grade 3-vs-Grade 4 |
4.706800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.35099999998278E-06 |
| Normal-vs-ccB subtype |
1.077130E-03 |
| ccA subtype-vs-ccB subtype |
2.556400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.960900E-04 |
| Normal-vs-N1 |
2.288300E-02 |
| N0-vs-N1 |
1.734170E-01 |
|
|
